| Literature DB >> 27364533 |
Ivan Jovanovic1, Maja Zivkovic1, Mirjana Kostic2,3, Zoran Krstic2,3, Tamara Djuric1, Ivana Kolic1, Dragan Alavantic1, Aleksandra Stankovic4.
Abstract
BACKGROUND: The genetic cause of most congenital anomalies of the kidney and urinary tract (CAKUT) cases remains unknown, therefore the novel approaches in searching for the common disease denominators are required. miRs regulate gene expression in humans and therefore have potentially therapeutic and biomarker properties. No studies thus far have attempted to explore the miRs in human CAKUT. We applied a new strategy to identify most specific miRs associated with CAKUT, in pediatric patients.Entities:
Keywords: Bioinformatics; Biomarker; CAKUT; Development; Integrative approach; MicroRNA; Microarray; Pediatric
Mesh:
Substances:
Year: 2016 PMID: 27364533 PMCID: PMC4929761 DOI: 10.1186/s12967-016-0955-0
Source DB: PubMed Journal: J Transl Med ISSN: 1479-5876 Impact factor: 5.531
Fig. 1Example of the unsupervised CIA. The plot shows the axes of the unsupervised CIA performed on the whole genome gene expression data of CAKUT patients and controls. The gene/miR frequency table generated with TargetScanS was used to make this figure. a Shows the projection of CAKUT and control samples. b Shows the projection of the miRs. Motifs in the opposite orientation relative to the origin are associated with that group of samples. Therefore, by the observation of the plots, miRs hsa-miR-144, hsa-miR-101, hsa-miR-183 and hsa-miR-375 are potentially associated with CAKUT according to their position
The most specific miRs predicted to be associated with CAKUT
| miRs from intersection | mirCos community | CIA average ranking |
|---|---|---|
|
| 4 |
|
| hsa-miR-101 | 4 | 10.5 |
|
| 7 |
|
|
| 7 |
|
|
| 1 |
|
| hsa-miR-495 | 1 | 12 |
| hsa-miR-222 | 70 | 6.5 |
The final list of miRs present both in CIA performed on sequence based miR target predictions and CIA performed on CoMeTa predictions. miRs from the same community that have higher average ranking were chosen for experimental validation (italics)
Fig. 2Difference in relative expression of hsa-miR-144, hsa-miR-183, hsa-miR-200a, and hsa-miR-375 between CAKUT patients (n = 36) and controls (n = 9). Relative miR levels were standardized against RNU44 endogenous control and presented as mean 2−ΔCt values ±SEM. Mann–Whitney U test was used to compare two unpaired groups of continuous variables that do not follow a normal distribution, **p ≤ 0.01
Differential expression of miRs in CAKUT group compared with controls
| micro RNA | Fold change | Man–Whitney U p value (two tailed) |
|---|---|---|
| hsa-miR-144 | 5.7 | 0.005 |
| hsa-miR-200a | 1.1 | 0.7 |
| hsa-miR-183 | 1.7 | 0.3 |
| hsa-miR-375 | 2.7 | 0.9 |
Fold change was calculated using 2−ΔCt values of relative miR levels standardized against RNU44 endogenous control
Fig. 3CoMeTa predicted hsa-miR-144 target genes contributing to biological processes involved in the development of CAKUT. The chart shows the relative ratio of the number of genes associated with different functional GO categories (biological processes). Biological process categories were selected according to biological meaning and the rule that GO analysis p values with Bonferroni adjustment must be ≤0.05. The number of CoMeTa predicted target genes of hsa-miR-144 associated with each category is shown in parentheses